Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

111.7000 SEK 4.8000 4.49%

As of 11:30:00 ET on 04/24/2015.

Company Profile for Swedish Orphan Biovitrum AB (SOBI)

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Contact Information

Swedish Orphan Biovitrum AB

Berzelius vaeg 8
Stockholm, SE-12276
Sweden
Phone: 46-8-697-20-00
Fax: 46-8-697-23-30

Key Executives for Swedish Orphan Biovitrum AB (SOBI)

Geoffrey McDonoughPresident/CEOMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
Dennis PedersenSenior VP/Head:MFG OpsFredrik BergVP/Gen Cnsl/Head:Legal & IP
Stefan FraenkelVP/Head:Corporate DevelopmentStephen JamesVP/Head:Drug Design & Dev
Cecilia FoerbergVP/Head:Project & PortfolioAnders EdvellVP/Head:Sobi Partner Products
Jorgen WinrothVP/Head:Investor RelationsWills Hughes-WilsonVP:External Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil